At Novartis Oncology our approach is simple. We call it "Think.Do."

Thinking is about harnessing the power of the imagination. It's about applying our pooled experience in new ways, exploring new possibilities and novel pathways, and finding better solutions for patients. Our primary goal is to research and develop new and more effective ways to treat cancer - in essence, to bring our vision of research to life.

Doing is about believing in our ability to change the way cancer is treated - and acting on this belief. Evidence of turning our thought into action can be seen in our array of innovative products signed to treat a variety of cancers. It is evident through our efforts in medical education, and through our unprecedented level of support, education, and financial assistance for patients.

Our mission is to become the world's premier oncology company by consistently discovering, developing, and producing broadly available novel therapies that improve and extend the lives of cancer patients. This site reviews how we are making a difference in oncology today, and how through our rich, broad, and deep pipeline, we are poised to shape cancer research treatment tomorrow.

Commitment to Patients ›

We are committed to building strong relationships with our patient advocacy partners.
More about our commitment to patients ›

Grant Requests ›

We offer you some of the best possible opportunities in the study of oncology
Learn more ›

CEO Cancer Gold Standard ›

Novartis Oncology Accredited as CEO Cancer Gold Standard™ Organization Learn more ›